Direct compression formulation of DPPIV inhibitors and glitazones, and process

Details for Australian Patent Application No. 2010212516 (hide)

Owner Novartis AG

Inventors Patel, Arun P.; Kowalski, James; Lakshman, Jay Parthiban

Agent Davies Collison Cave

Pub. Number AU-A-2010212516

Parent 2006258013

Filing date 24 August 2010

Wipo publication date 16 September 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

9 September 2010 Complete Application Filed

16 September 2010 Application Open to Public Inspection

  Published as AU-A-2010212516

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212517-Opioid and opioid-like compounds and uses thereof

2010212515-Capsule Endoscope